Autonomix Announces 1-for-21 Reverse Stock Split to Maintain Nasdaq Listing
AMIX sits 72% above its 52-week low of $0.2 on light trading volume (0.3× avg).
Summary
Autonomix Medical announced a 1-for-21 reverse stock split, effective June 24, 2026. This action directly addresses the Nasdaq delisting threat disclosed in the company's May 27, 2026 10-K filing, which cited a going concern warning and material weaknesses. The split aims to increase the share price above the minimum bid requirement, which is critical for maintaining the company's Nasdaq listing and access to public capital markets. Post-split, the share count will reduce from approximately 11.4 million to 543,000.
At the time of this announcement, AMIX was trading at $0.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.2M. The 52-week trading range was $0.20 to $2.64. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.